Avingtrans plcLSE: AVG

Avingtrans: Adaptix signs MOU with IBEX on bone health

· Issued by Avingtrans plc via RNS

Summary by 6ix AI

Avingtrans plc, which supplies components, systems and services to the energy, medical and industrial sectors, said its medical imaging subsidiary Adaptix Ltd has signed a memorandum of understanding (MOU), a preliminary written agreement, with IBEX Innovations Ltd to integrate IBEX's CorteX bone health software into Adaptix's Ortho350 portable 3D X-ray imaging system.

Key details

  • The two companies aim to offer patients a pay-per-scan bone density report at the point of care, meaning where the patient is seen. Avingtrans says preliminary surveys indicated patients would welcome this if offered on a cash-pay basis alongside other routine clinical assessments.
  • According to the companies, CorteX outputs the same recognised clinical measures as dual-energy X-ray absorptiometry (DXA), a bone density scan, with a low T-score (a bone density score) at the wrist being an established indicator of higher fracture risk and general bone loss.
  • The Ortho350 has US Food and Drug Administration 510(k) clearance (a US route to market) and the European CE mark. It is a portable 3D X-ray system designed to provide high-resolution, low-dose 3D imaging of bones and joints, offered as a more accessible alternative to full CT scans.
  • Stuart Gall, Chief Executive Officer of Avingtrans's Medical and Industrial Imaging Division, said IBEX has been asked to join their exhibition stand, Stand 3159, South Hall, Level 3, at RSNA 2026 (Radiological Society of North America) in Chicago, and invited imaging centres, hospitals and equipment makers to visit.

What’s still pending

  • CorteX's US Food and Drug Administration 510(k) submission is pending, and it is not yet available for commercial distribution or sale in the United States.
  • The arrangement is a memorandum of understanding; the integration and pay-per-scan offering are stated as aims.

6ix AI wrote this summary from the release below and checked it against the release.

Avingtrans PLC
17 November 2026

17 November 2026

Avingtrans plc

("Avingtrans", the "Company", or the "Group")

Adaptix signs MOU with IBEX on bone health

Avingtrans plc (AIM: AVG), which designs, manufactures and supplies critical components, modules, systems and associated services to the energy, medical and industrial sectors, is pleased to announce that its medical imaging subsidiary, Adaptix Ltd (“Adaptix”), has signed a Memorandum of Understanding (“MOU”) with IBEX Innovations Ltd (“IBEX”) to integrate IBEX’s CorteX bone health software into Adaptix’s FDA 510(k) cleared and CE marked Ortho 3D X-ray Imaging System (the “Ortho350”).

By integrating CorteX into the Ortho350 portable 3D X-ray imaging platform, the two companies aim to provide patients with a pay-per-scan bone density report at the point of care (“POC”), making bone density assessment widely available. Preliminary surveys indicated that this would be strongly welcomed by patients if offered on a cash-pay basis alongside other routine clinical assessments.

CorteX outputs the same recognised clinical biomarkers as dual-energy X-ray absorptiometry (“DXA”), with a low T-score at the wrist being an established indicator of elevated fracture risk and general bone loss, a key concern, particularly for women approaching the menopause. The CorteX software is FDA 510(k) submission pending and is not yet available for commercial distribution or sale in the United States.

The Ortho350 is a portable Digital Tomosynthesis system designed to provide high-resolution, low-dose 3D imaging for musculoskeletal diagnostics at the POC. The system addresses the limitations of traditional 2D X-ray imaging while offering a more accessible alternative to full CT scans.

Dr Paul Scott, Chief Executive Officer of IBEX, commented:

“Together we are bringing bone health assessment to the physician’s desktop. This is transformational for patients who often only become aware of a problem once a fracture has occurred. Making bone health assessment fast, easy and widely accessible is the missing ingredient to support clinicians in stopping osteoporosis in its tracks.”

Stuart Gall, Chief Executive Officer of the Medical and Industrial Imaging Division at Avingtrans, commented:

“We are excited to be taking this first step with IBEX and working with them to bring their excellent bone density test to market on the Ortho350 imaging platform. We have asked them to join our exhibition stand at RSNA 2026 in Chicago and would welcome any imaging centres, hospitals or interested OEMs to visit us on Stand 3159, South Hall, Level 3.”

- ENDS -

Enquiries:

Avingtrans plc

013 5469 2391

Roger McDowell, Chairman

Steve McQuillan, Chief Executive Officer

Stephen King, Chief Financial Officer

Singer Capital Markets (Nominated Adviser and Broker)

020 7496 3000

Shaun Dobson

Alex Bond

Daniel Ingram

IFC Advisory (Financial PR)

020 3934 6630

Graham Herring

Tim Metcalfe

Zach Cohen

About Avingtrans plc:

Avingtrans designs, manufactures and supplies original equipment, systems and associated aftermarket services to the energy, medical and industrial markets worldwide.

Business units

Hayward Tyler - Luton, East Kilbride UK, USA, China and India

Specialises in the design, manufacture and servicing of performance-critical motors and pumps for challenging environments.

Energy Steel, Inc - Rochester Hills, Michigan, USA

Provider of custom fabrications for the nuclear industry, specialising in: OEM parts obsolescence; custom fabrications; engineering design solutions; product refurbishment; on-site technical support.

Stainless Metalcraft Ltd - Chatteris, UK

Provider of safety-critical equipment for the energy, medical, science and research communities, worldwide, specialising in precision pressure and vacuum vessels and associated fabrications, sub-assemblies and systems.

Booth Industries - Bolton, UK

Designs, manufactures, installs and services doors and walls which can be tailored to be: blast and explosion proof; fireproof; acoustically shielded; high security/safety; or combinations of the above.

Ormandy Group - Bradford, UK

Design, manufacturers and servicing of off-site plant, heat exchangers and other HVAC (heating, ventilation and air conditioning) products.

Slack & Parr - Kegworth, UK, USA & China

Design, manufacture and servicing of high-precision gear metering pumps, hydraulics flow dividers and industrial pumps.

Composite Products Ltd - Buckingham, UK

Centre for composite technology, parts and assemblies, serving customers in industrial markets.

Adaptix Ltd - Oxford, UK

Adaptix has developed novel 3D X-ray for Orthopaedic and Veterinary applications amongst others. Commercialisation of this system (and others) is on-going.

Magnetica Ltd - Brisbane, Australia

Magnetica Limited specialises in the development of next generation MRI technologies, including dedicated extremity MRI systems and MRI system components. Magnetica has successfully built and tested a compact, integrated 3 Tesla orthopaedic MRI system, demonstrating clinical-quality imaging. Commercialisation of this system (and others) is on-going. Magnetica's structure now includes two other business units:

Scientific Magnetics - Abingdon, UK

Designs and manufactures superconducting magnet systems and associated cryogenics for a variety of markets including MRI and provides services for Nuclear Magnetic Resonance instruments.

Tecmag Inc - Houston, USA

Designs, manufactures and installs instrumentation, including consoles, system upgrades, and probes, mainly for Magnetic Resonance Imaging (MRI) and Nuclear Magnetic Resonance (NMR) systems.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

Avingtrans plc on 6ix

Story so far

Earlier from Avingtrans

All Avingtrans news releases